Cargando…
MicroRNA200a Enhances Antitumor Effects in Combination with Doxorubicin in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is often treated with doxorubicin. MicroRNAs have been shown to have important regulatory roles in cancer and serve as a target in chemoresistance. In this study, we investigated the effects of specific microRNA-200a (miR-200a) on HCC tumor cell growth and effect of do...
Autores principales: | Cui, Xiao, Zhou, Dachen, Du, Qiang, Wan, Peiqi, Dong, Kun, Hou, Hui, Geller, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305444/ https://www.ncbi.nlm.nih.gov/pubmed/32563177 http://dx.doi.org/10.1016/j.tranon.2020.100805 |
Ejemplares similares
-
Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma
por: Dhayat, Sameer A., et al.
Publicado: (2015) -
Enhanced antitumor efficacy of doxorubicin-encapsulated halloysite nanotubes
por: Li, Kai, et al.
Publicado: (2017) -
MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells
por: Yan, Yihe, et al.
Publicado: (2016) -
Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines
por: Takuma, Kei, et al.
Publicado: (2022) -
Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway
por: Guangshun, Sun, et al.
Publicado: (2022)